A new jab designed to help people lose weight will be more widely available in the UK thanks to a multimillion-pound trial. The Government is spending £40million on the pilot scheme aimed at improving health.
Under the trial, the Wegovy (semaglutide) jab will be made easier to access for those with a body mass index of 35 or higher. The drug was approved by The National Institute for Health and Care Excellence (NICE) earlier this year but said it should only be made available through specialist services, such as those in hospitals.
The drug suppresses the appetite of the patient with the aim of reducing the amount of food they eat. It is hoped that the injection could help treat conditions such as high blood pressure and diabetes.
